Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2025)
Lucid Diagnostics (LUCD) has disclosed Return on Capital Employed for 5 consecutive years, with 2.43% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Capital Employed rose 77.0% year-over-year to 2.43%, compared with a TTM value of 2.43% through Sep 2025, up 77.0%, and an annual FY2024 reading of 8.42%, up 8711.0% over the prior year.
- Return on Capital Employed was 2.43% for Q3 2025 at Lucid Diagnostics, up from 7.6% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.92% in Q1 2025 and bottomed at 55.41% in Q4 2023.
- Average Return on Capital Employed over 5 years is 6.26%, with a median of 2.75% recorded in 2023.
- The sharpest move saw Return on Capital Employed tumbled -5332bps in 2023, then surged 4071bps in 2024.
- Year by year, Return on Capital Employed stood at 1.02% in 2021, then crashed by -104bps to 2.08% in 2022, then plummeted by -2560bps to 55.41% in 2023, then soared by 73bps to 14.7% in 2024, then surged by 83bps to 2.43% in 2025.
- Business Quant data shows Return on Capital Employed for LUCD at 2.43% in Q3 2025, 7.6% in Q2 2025, and 9.92% in Q1 2025.